Licensing deal
Exelixis partners with AI company Insilico to discover new drugs, LIB sells China rights for PCSK9 drug
Anika Sharma
Exelixis, the pharmaceutical company recognized for its solid tumor medication Cabometyx, is adopting artificial intelligence (AI) to bolster its pipeline. ...
The legacy of Bristol Myers and BeiGene Celgene’s payment comes years after China’s prohibition
SG Tylor
In 2020, an unexpected manufacturing issue led to a ban on the import of Bristol Myers Squibb’s (BMS) Abraxane, distributed ...
